Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 339

Gyroscope enters Orbit for merger

Gyroscope Therapeutics, spun out of Cambridge and Syncona, has merged with Orbit Biomedical to form a fully-integrated retinal gene therapy developer.

Apr 18, 2019

Salary Finance rallies series C funding

Legal & General co-led the $32.8m series C round, which will fund the financial wellbeing platform's growth in the UK and US.

Apr 18, 2019

SEB pitches stall at Fairpoint

SEB has formed a venture capital vehicle, Fairpoint Capital, to invest in B2B-focused startups out of a $97m fund with ex-SEB Venture Capital president Frederick Johansson as its head.

Apr 18, 2019

Neurallys finds $850,000 alibi

IDF Innov-allied brain implant developer Neurallys plans to market sensors that measure intracranial pressure to combat the severe neurological complication hydrocephalus.

Apr 17, 2019

Cytora slides into series B round

QBE and Starr Companies-backed insurance underwriting software provider Cytora has secured $32.6m in an EQT Ventures-led round.

Apr 17, 2019

Cytora assesses $32.6m series B

Cambridge Innovation Capital and Parkwalk Advisors have both returned to back a $32.6m series B round for Cytora, an insurance technology spinout of Cambridge.

Apr 17, 2019

Metry measures $1.5m investment

Chalmers Ventures has contributed to a $1.5m funding round for cleantech developer Metry.

Apr 17, 2019

Vestas blows into Sowitec

The wind turbine maker has bought just over 25% of Sowitec, in the process securing a three-year option to wholly acquire the solar and wind project developer.

Apr 17, 2019

Microlight3D binds to Smart Force Technologies

Microelectronics Technology Laboratory spinout Smart Force Technologies’ mask-less 2D microfabrication technology will be integrated with new 3D printers developed by Microlight3D.

Apr 16, 2019

Boehringer Ingelheim regenerates Agomab

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer spun out of University of Turin.

Apr 16, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here